|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
| 2 | Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates tobody composition, muscular functional capacity, and peripheral blood flow显示文摘 | Doehner W Bunck AC Rauchhaus M | 2007 | Eur Heart J2007，28，7： | 1 |
| 3 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck M C Diamant M Corner A | 2009 | Diabetes Care2009，32，： | 1 |
| 4 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial 显示文摘 | BUNCK M C DIAMANT M CORNIER A | 2013 | Diabetes Care2013，32，5： | 1 |
| 5 | Exenatide affectscirculating cardiovascular risk biomarkers independently ofchanges in body composition显示文摘 | Bunck MC Diamant M Eliasson | 2010 | Diabetes Care2010，33，8： | 1 |
| 6 | One-year treatment with exenatide improves beta-cell function, compared with insulin glagine , in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 7 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Cornér A | | 0，，： | 1 |
| 8 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck M C Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 9 | One- year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin- treated type 2 diabetic patients : a randomized, controlled trial显示文摘 | BUNCK MC DIAMANT M CORNER A | 2009 | Diabetes Care2009，32，5： | 1 |
| 10 | Co - segregation of hy- peractivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety显示文摘 | Yen YC Anderzhanova E Bunck M | 2013 | Front Behav Neurosci2013，7，103： | 1 |
| 11 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metfonnin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes care2009，32，5： | 1 |
| 12 | Growth and morphometrics of the boxturtle, Terrapene carolina显示文摘 | STICKEL L F BUNCK C M | 1989 | Journal of Herpetology1989，23，3： | 1 |
| 13 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin- treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
| 14 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Cornier A | | 0，，05： | 1 |
| 15 | Incretin mi metics as a novel therapeutic option for hepatic steatosis显示文摘 | Tushuizen M E Bunck M C Pouwels P J | 2006 | Liver Int2006，26，8： | 1 |
| 16 | Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia:a randomised controlled trial显示文摘 | Foley JE Bunck MC M(o)ller-Goede DL | | 0，，08： | 1 |
| 17 | One-year treatment with exenatide improves 显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 18 | One-year treatment with exenatide improves beta-cell funtion,compared with insulin glargine,in metformin-treated type 2 diabetes patients:a randomized,controled trail显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 19 | Oen-year treatment with ex-enatide improvesβ-cell function,compared with insulin glargine,in metform in-treated type 2diabetic patients:a randomized,controlledtria1显示文摘 | Bunck M C Diamant M Comer A et a1 | 2009 | Diabetes Care2009，32，5： | 1 |
| 20 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员